The efficacy of agomelatine appears to extend to generalised anxiety disorder (GAD)

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1660, 2008-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder

By Buoli Massimiliano Mauri Massimo Carlo Altamura Alfredo Carlo

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 885-892

Informa Healthcare

Access to resources Recommend Favorite

Both bupropion and escitalopram reduce anxiety in generalised anxiety disorder (GAD), but bupropion is associated with greater benefits

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Agomelatine in treating generalized anxiety disorder

By Demyttenaere Koen

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 857-864

Informa Healthcare

Access to resources Recommend Favorite

Pregabalin: In the Treatment of Generalised Anxiety Disorder

By Frampton James E. Foster Rachel H.

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 685-693

Adis International

Access to resources Recommend Favorite

Generalised Anxiety Disorder: Treatment Options

By Sramek J.J.

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1635-1648

Adis International

Access to resources Recommend Favorite